Gene Therapy Co. Sangamo Gets Initial OK For $30M DIP
A Delaware bankruptcy judge on Wednesday granted interim approval of a $30 million Chapter 11 financing package for biotechnology company Sangamo Therapeutics Inc., funds that the debtor will use to support a...To view the full article, register now.
Already a subscriber? Click here to view full article